7 Patents
- US12359201202517ß-hydroxysteroid Dehydrogenase Type 13 (HSD17B13) Irna Compositions and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US122866772025Inhibition of HSD17B13 in the Treatment of Liver Disease in Patients Expressing the PNPLA3 I148M Variation
Regeneron Pharmaceuticals, Inc.
0 cites - US122509312025Genetically Modified Mouse with a Humanized PNPLA3 Gene and Methods of Use
REGENERON PHARMACEUTICALS, Inc.
0 cites - US121395462024Methods of Treating Urea Cycle Disorders by Interfering with Glucagon Receptor Signaling
REGENERON PHARMACEUTICALS, Inc.
0 cites - 0 cites
- 0 cites
- US117027002023Inhibition of HSD17B13 in the Treatment of Liver Disease in Patients Expressing the PNPLA3 I148M Variation
Regeneron Pharmaceuticals, Inc.
0 cites